Schedule 13D ownership disclosure

CEREVEL THERAPEUTICS HLDNG I

Security class unavailable · CUSIP: 15678U128

Event date: 2020-10-27

Legacy cover-page extraction is best effort and may not include every reporting person.

Filing-level shares
27,349,211
Percent of class
21.5000%

Amounts are as disclosed in this filing. Schedule type alone does not establish investment intent.

Source: SEC EDGAR filing

Filing metadata

Accession number
0000078003-20-000074
Form type
SC 13D
Filer
Cerevel Therapeutics Holdings, Inc.
CIK
CIK 1805387
Filed
Nov 06, 2020
Reporting period
Oct 27, 2020
Description
Schedule 13D beneficial ownership

Explore SEC Filings Hub